After FDA sign-off, Colorado’s drug import plan faces tough road ahead

Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own hands, albeit through a framework that may be difficult to pull off in the real world.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks